office
(508) 653-2379
email jan.krouwer@comcast.net
* means this is a top ten read essay
It's
time to stop advocating the use of the
wrong model in clinical chemistry
*Six
Sigma I Some technical comments about Six Sigma in the lab
Six Sigma II A glucose
example and its problems
Six Sigma III A
dubious Six Sigma claim
Troponin I – Its Performance
Doesn’t Justify Actions
*How to specify and
estimate outlier rates
A Comment about GUM
Why Progress in
Quality is Slow
Equivalent QC
Equivalent QC II
Should labs run more QC?
Issues with Standard
Groups
ISO Terminology - Globally
harmonized or gobbledygook
FMEA vs.
lab performance goals - there's a big difference
Comments on the FDA
Guidance for Waiver Applications
*Fault tree
example as an aid to completing a FMEA
*Risk Management
Publishing in Journals or on
the web
It's Up To the Lab
Director
The quality of
quality initiatives
Discrepant Analysis
QC Outlier............s
Uniformity of
Claims
Proficiency testing and six sigma
More on GUM
Fault
Isolation
*Bland
Altman Plots
Customer Misuse
Risk
Management II
Unit use
devices, POC and QC
Risk Management III
What it takes to get
your idea accepted
Pedigree of Error
Reduction Approaches
Frequency of
Preventable Medical Errors – Myth or Reality
Focus on systems, not
people
*The anatomy of a near
miss
Detection in FMEA - why it
should not be included in a Pareto ranking
Recovery in FMEA
Latent errors
Preventable medical
errors: Preventability and regulation
*FMEA
vs. FRACAS vs. RCA
Pay for performance -
the missing measure
*FMEA
Validation
Frequency of
Preventable Medical Errors II - Where's the data
Pay
for Performance II
Error Reporting
Systems
The Reverse Pareto - not
a good idea
When to conduct a
FMEA
FMEA FRACAS Fault Trees
and Pareto
*How
to write a report that will be read
Beware the
technical Administrator
Let’s just dump the lab data
on the Internet – not that easy
Software Validation